Airway Resistome Higher In Chronic Lung Disease
Recent antibiotic exposure was linked to greater antimicrobial resistance gene burden in bronchoscopy samples of patients with chronic lung disease.
-
By
-
Andrea Surnit
-
March 27, 2026
-
Clinical Scorecard: Airway Resistome Higher In Chronic Lung Disease
At a Glance
| Category | Detail |
|---|
| Condition | Chronic Lung Disease |
| Key Mechanisms | Higher prevalence of antimicrobial resistance genes in lower airway microbiome. |
| Target Population | Patients with chronic lung diseases such as sarcoidosis, idiopathic pulmonary fibrosis, and COPD. |
| Care Setting | Clinical research setting involving bronchoscopy and metagenomic sequencing. |
Key Highlights
- Patients with sarcoidosis and IPF showed the highest odds of harboring antimicrobial resistance genes.
- Tetracycline resistance genes were found in 33% of samples, with higher prevalence in chronic lung disease patients.
- Recent antibiotic exposure significantly increased the burden of resistance genes.
Guideline-Based Recommendations
Diagnosis
- Utilize bronchoscopy with sterile sampling for accurate assessment of airway resistome.
Management
- Monitor antibiotic use and its impact on resistance gene prevalence in chronic lung disease patients.
Monitoring & Follow-up
- Regular assessment of lung function and resistance gene counts in patients with chronic lung diseases.
Risks
- Increased risk of antimicrobial resistance in patients with sarcoidosis and IPF.
Patient & Prescribing Data
Patients with chronic lung diseases, particularly those with a history of exacerbations.
Antibiotic exposure within 3 months correlates with higher resistance gene counts.
Clinical Best Practices
- Avoid unnecessary antibiotic prescriptions in chronic lung disease patients.
- Educate patients on the risks of antibiotic use and resistance.
References
